Clermont-Ferrand, France

Jean-Claude Madelmont

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 8.2

ph-index = 1


Company Filing History:


Years Active: 2015-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Jean-Claude Madelmont

Introduction

Jean-Claude Madelmont is a notable inventor based in Clermont-Ferrand, France. He has made significant contributions to the field of medical imaging through his innovative patents. With a total of two patents to his name, Madelmont's work focuses on the development of compounds used in diagnostic imaging.

Latest Patents

Madelmont's latest patents include "Macrocyclic complexes, their process of preparation and use as PET imaging agents." This invention concerns compounds of a specific formula and their preparation processes, as well as their application as diagnostic agents in PET imaging. Another significant patent is "Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors." This invention relates to a compound of a specific formula and includes pharmaceutical compositions that utilize these compounds for diagnosis, particularly in SPECT or PET imaging, and in the therapy of melanoma through targeted radionuclide therapy.

Career Highlights

Throughout his career, Jean-Claude Madelmont has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université d'Auvergne Clermont 1. His work in these organizations has allowed him to advance his research and contribute to the field of medical imaging.

Collaborations

Madelmont has collaborated with notable colleagues, including Elisabeth Miot-Noirault and Jean-Michel Chezal. These collaborations have further enriched his research and innovations in the field.

Conclusion

Jean-Claude Madelmont's contributions to medical imaging through his patents demonstrate his commitment to advancing healthcare technology. His innovative work continues to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…